Zealand Pharma saw the highest growth of 99% in patent filings and 199% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 70% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Zealand Pharma‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Zealand Pharma has been focused on protecting inventions in United States(US) with seven publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 38% filings and 40% grants. The United States(US), Chile(CL), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Zealand Pharma is filings its patents. Among the top granted patent authorities, Zealand Pharma has 40% of its grants in United States(US) and 40% in European Patent Office(EPO).

Immatics and F. Hoffmann-La Roche could be the strongest competitors for Zealand Pharma

Patents related to rare diseases and climate change lead Zealand Pharma's portfolio

Zealand Pharma has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 100% of patents were filed and 50% of patents were granted in Q1 2024.

Obesity related patents lead Zealand Pharma portfolio followed by short bowel syndrome, and ileitis

Zealand Pharma has highest number of patents in obesity followed by short bowel syndrome, ileitis, inflammatory bowel disease, and ulcerative colitis. For obesity, nearly 4% of patents were filed and 13% of patents were granted in Q1 2024.

For comprehensive analysis of Zealand Pharma's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.